Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FGFR2 |
| Upstream (Parents) |
|---|
| (<<) BLNK → FGFR2 |
| (<<) E2F4 → FGFR2 |
| (<<) ELF4 → FGFR2 |
| (<<) GNA15 → FGFR2 |
| (<<) GNB5 → FGFR2 |
| (<<) GOT1 → FGFR2 |
| (<<) HGS → FGFR2 |
| (<<) HSD17B2 → FGFR2 |
| (<<) HYAL1 → FGFR2 |
| (<<) LARP6 → FGFR2 |
| (<<) NNMT → FGFR2 |
| (<<) NUDT6 → FGFR2 |
| (<<) ORM1 → FGFR2 |
| (<<) PNPLA3 → FGFR2 |
| (<<) RDH16 → FGFR2 |
| (<<) RNASE4 → FGFR2 |
| (<<) RORA → FGFR2 |
| (<<) SOD1 → FGFR2 |
| (<<) ST3GAL6 → FGFR2 |
| (<<) STAT1 → FGFR2 |
| (<<) UGDH → FGFR2 |
| Downstream (Children) |
|---|
| FGFR2 → CKB (>>) |
| FGFR2 → CLK3 (>>) |
| FGFR2 → ENC1 (>>) |
| FGFR2 → ENO3 (>>) |
| FGFR2 → FAS (>>) |
| FGFR2 → GALR3 (>>) |
| FGFR2 → GNE (>>) |
| FGFR2 → INSR (>>) |
| FGFR2 → MAP3K14 (>>) |
| FGFR2 → MAP3K4 (>>) |
| FGFR2 → NFIB (>>) |
| FGFR2 → STAT2 (>>) |
